脂质代谢相关长非编码 RNA：肝细胞癌潜在的预后生物标志物。
Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinoma.
机构信息
Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
出版信息
World J Gastroenterol. 2024 Sep 7;30(33):3799-3802. doi: 10.3748/wjg.v30.i33.3799.
Abstract
The incidence rates of hepatocellular carcinoma (HCC) have increased in recent decades. Despite advancements in therapy and early diagnosis improving short-term prognosis, long-term outcomes remain poor. Long noncoding RNAs (lncRNAs) and lipid metabolism play crucial roles in the development and progression of HCC. Enhanced lipid synthesis promotes HCC progression, and lncRNAs can reprogram the expression of lipogenic enzymes. Consequently, lipid metabolism-related (LMR)-lncRNAs regulate lipid anabolism, accelerating the onset and progression of HCC. This suggests that LMR-lncRNAs could serve as novel prognostic biomarkers and therapeutic targets.
摘要
近年来，肝细胞癌（HCC）的发病率有所上升。尽管治疗和早期诊断方面的进展提高了短期预后，但长期结果仍然不佳。长链非编码 RNA（lncRNA）和脂质代谢在 HCC 的发生和发展中起着关键作用。增强的脂质合成促进 HCC 的进展，lncRNA 可以重新编程生脂酶的表达。因此，与脂质代谢相关的（LMR）-lncRNA 调节脂质合成，加速 HCC 的发生和发展。这表明 LMR-lncRNA 可以作为新的预后生物标志物和治疗靶点。
相似文献
1
Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinoma.脂质代谢相关长非编码 RNA：肝细胞癌潜在的预后生物标志物。
World J Gastroenterol. 2024 Sep 7;30(33):3799-3802. doi: 10.3748/wjg.v30.i33.3799.
2
Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma.脂质代谢相关长非编码 RNA RP11-817I4.1 促进肝癌中脂肪酸的合成和肿瘤进展。
World J Gastroenterol. 2024 Feb 28;30(8):919-942. doi: 10.3748/wjg.v30.i8.919.
3
Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.长链非编码 RNA AWPPH 通过 YBX1 促进肝细胞癌进展，并作为一种预后生物标志物。
Biochim Biophys Acta Mol Basis Dis. 2017 Jul;1863(7):1805-1816. doi: 10.1016/j.bbadis.2017.04.014. Epub 2017 Apr 18.
4
Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.长链非编码RNA作为生物标志物和治疗靶点：肝细胞癌的最新见解
Life Sci. 2017 Dec 15;191:273-282. doi: 10.1016/j.lfs.2017.10.007. Epub 2017 Oct 4.
5
Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.长链非编码 RNA UPK1A-AS1 提示肝细胞癌预后不良，并通过与 EZH2 相互作用促进细胞增殖。
J Exp Clin Cancer Res. 2020 Oct 29;39(1):229. doi: 10.1186/s13046-020-01748-y.
6
Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.长链非编码 RNA 在肝细胞癌中的作用：潜在的作用和临床意义。
World J Gastroenterol. 2017 Aug 28;23(32):5860-5874. doi: 10.3748/wjg.v23.i32.5860.
7
A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.一种新型长链非编码 RNA RP11-386G11.10 重编程脂质代谢促进肝癌进展。
Mol Metab. 2022 Sep;63:101540. doi: 10.1016/j.molmet.2022.101540. Epub 2022 Jul 5.
8
Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.长链非编码RNA（lncRNAs）在肝细胞癌中的研究进展与展望
Cell Physiol Biochem. 2015;36(2):423-34. doi: 10.1159/000430109. Epub 2015 May 11.
9
RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.RNA 测序揭示长非编码 RNA 和 mRNA 谱，并鉴定长非编码 RNA TSPAN12 为肝癌微血管侵犯相关的潜在生物标志物。
Biomed Pharmacother. 2020 Jun;126:110111. doi: 10.1016/j.biopha.2020.110111. Epub 2020 Mar 26.
10
The role of long noncoding RNAs in hepatocellular carcinoma.长链非编码 RNA 在肝细胞癌中的作用。
Mol Cancer. 2020 Apr 15;19(1):77. doi: 10.1186/s12943-020-01188-4.
引用本文的文献
1
A nine-gene signature with potential targets for predicting the prognosis of patients with esophageal cancer.一种具有潜在靶点的九基因特征，用于预测食管癌患者的预后。
Transl Cancer Res. 2025 Jul 30;14(7):4305-4320. doi: 10.21037/tcr-2025-146. Epub 2025 Jul 24.
2
Multifaceted roles of lactate dehydrogenase in liver cancer (Review).乳酸脱氢酶在肝癌中的多方面作用（综述）
Int J Oncol. 2025 Jun;66(6). doi: 10.3892/ijo.2025.5756. Epub 2025 May 26.
本文引用的文献
1
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies.肝细胞癌与脂代谢：新靶点与治疗策略。
Cancer Lett. 2024 Aug 10;597:217061. doi: 10.1016/j.canlet.2024.217061. Epub 2024 Jun 13.
2
Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice.肝细胞癌-基础肝病在临床实践中的作用。
World J Gastroenterol. 2024 May 21;30(19):2488-2495. doi: 10.3748/wjg.v30.i19.2488.
3
Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma.脂质代谢相关长非编码 RNA RP11-817I4.1 促进肝癌中脂肪酸的合成和肿瘤进展。
World J Gastroenterol. 2024 Feb 28;30(8):919-942. doi: 10.3748/wjg.v30.i8.919.
4
Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker.中胚层来源蛋白（MDK）在肝细胞癌中的作用：不止是一种生物标志物。
Cells. 2024 Jan 11;13(2):136. doi: 10.3390/cells13020136.
5
Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肝细胞癌和肝外癌症风险。
Lancet Gastroenterol Hepatol. 2024 Feb;9(2):159-169. doi: 10.1016/S2468-1253(23)00275-3.
6
HCC-Related lncRNAs: Roles and Mechanisms.HCC 相关长链非编码 RNA：作用与机制。
Int J Mol Sci. 2024 Jan 2;25(1):597. doi: 10.3390/ijms25010597.
7
Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma.活检之战：组织活检与液体活检在肝细胞癌中的作用
J Hepatol. 2024 Mar;80(3):515-530. doi: 10.1016/j.jhep.2023.11.030. Epub 2023 Dec 15.
8
Non-coding RNAs in disease: from mechanisms to therapeutics.非编码 RNA 在疾病中的作用：从机制到治疗。
Nat Rev Genet. 2024 Mar;25(3):211-232. doi: 10.1038/s41576-023-00662-1. Epub 2023 Nov 15.
9
Long non-coding RNAs in hepatocellular carcinoma.肝细胞癌中的长链非编码RNA
Pathol Res Pract. 2023 Aug;248:154604. doi: 10.1016/j.prp.2023.154604. Epub 2023 Jun 8.
10
A Statistical Approach to the Diagnosis and Prediction of HCC Using CK19 and Glypican 3 Biomarkers.一种使用CK19和磷脂酰肌醇蛋白聚糖3生物标志物对肝癌进行诊断和预测的统计方法。
Diagnostics (Basel). 2023 Mar 27;13(7):1253. doi: 10.3390/diagnostics13071253.
Zotero 插件